PT Etana Biotechnologies Indonesia (Etana) is an Indonesian biopharmaceutical company focused on the research, development, and production of innovative and affordable biological therapies. Established in 2014, it addresses a range of metabolic, autoimmune, and life-threatening diseases, including cancer. Through strategic global partnerships and advanced local manufacturing capabilities, Etana expands access to high-quality treatments while supporting the growth of Indonesia’s healthcare and pharmaceutical ecosystem.